Myc controls transcriptional regulation of cardiac metabolism and mitochondrial biogenesis in response to pathological stress in mice
Open Access
- 3 May 2010
- journal article
- research article
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 120 (5), 1494-1505
- https://doi.org/10.1172/jci38331
Abstract
In the adult heart, regulation of fatty acid oxidation and mitochondrial genes is controlled by the PPARγ coactivator–1 (PGC-1) family of transcriptional coactivators. However, in response to pathological stressors such as hemodynamic load or ischemia, cardiac myocytes downregulate PGC-1 activity and fatty acid oxidation genes in preference for glucose metabolism pathways. Interestingly, despite the reduced PGC-1 activity, these pathological stressors are associated with mitochondrial biogenesis, at least initially. The transcription factors that regulate these changes in the setting of reduced PGC-1 are unknown, but Myc can regulate glucose metabolism and mitochondrial biogenesis during cell proliferation and tumorigenesis in cancer cells. Here we have demonstrated that Myc activation in the myocardium of adult mice increases glucose uptake and utilization, downregulates fatty acid oxidation by reducing PGC-1α levels, and induces mitochondrial biogenesis. Inactivation of Myc in the adult myocardium attenuated hypertrophic growth and decreased the expression of glycolytic and mitochondrial biogenesis genes in response to hemodynamic load. Surprisingly, the Myc-orchestrated metabolic alterations were associated with preserved cardiac function and improved recovery from ischemia. Our data suggest that Myc directly regulates glucose metabolism and mitochondrial biogenesis in cardiac myocytes and is an important regulator of energy metabolism in the heart in response to pathologic stress.This publication has 85 references indexed in Scilit:
- Cyclin-dependent kinase 2 signaling regulates myocardial ischemia/reperfusion injuryJournal of Molecular and Cellular Cardiology, 2008
- Mitochondrial Fusion Is Increased by the Nuclear Coactivator PGC-1βPLOS ONE, 2008
- Energy metabolism in heart failure and remodellingCardiovascular Research, 2008
- Cardioselective dominant-negative thyroid hormone receptor (Δ337T) modulates myocardial metabolism and contractile efficiencyAmerican Journal of Physiology-Endocrinology and Metabolism, 2008
- Transcriptional coactivators PGC-1α and PGC-lβ control overlapping programs required for perinatal maturation of the heartGenes & Development, 2008
- Alterations in energy metabolism in cardiomyopathiesAnnals of Medicine, 2007
- Hypertrophic growth in cardiac myocytes is mediated by Myc through a Cyclin D2-dependent pathwayThe EMBO Journal, 2006
- c-Myc-regulated microRNAs modulate E2F1 expressionNature, 2005
- PGC-1α Deficiency Causes Multi-System Energy Metabolic Derangements: Muscle Dysfunction, Abnormal Weight Control and Hepatic SteatosisPLoS Biology, 2005
- Developmental changes in energy substrate use by the heartCardiovascular Research, 1992